Vimarsana
Biggest News Aggregation in the World

Page 4 - Edication Pricing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Edication Pricing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Edication Pricing Today - Breaking & Trending Today

US to Select 10 Costliest Drugs for Medicare Pricing Negotiation - Vimarsana News

US to Select 10 Costliest Drugs for Medicare Pricing Negotiation

The US government will select the 10 costliest prescription medicines to Medicare for negotiating prices with drugmakers starting early next year, the program's top official said on Friday.

US Proposes Medicare, Medicaid Programs to Cut Drug Costs, Including $2 Generics - Vimarsana News

US Proposes Medicare, Medicaid Programs to Cut Drug Costs, Including $2 Generics

The US health department proposed on Tuesday three new pilot projects aimed at lowering prescription drug prices for people enrolled in government health insurance plans.

US Government to Start Imposing Inflation Penalties on Drugmakers in 2025 - Vimarsana News

US Government to Start Imposing Inflation Penalties on Drugmakers in 2025

The US government will begin imposing penalties in 2025 on drug companies that charge its Medicare program prices that rise faster than inflation, the Centers for Medicare & Medicaid Services said on Thursday.

Why Europe's Drug Shortages May Get Worse - Vimarsana News

Why Europe's Drug Shortages May Get Worse

When Ignasi Biosca-Reig heard there were shortages of amoxicillin in Spain, he quickly added shifts at his drug company's factories to boost production of the popular antibiotic. But a few extra shifts was as far as he could go.

Biden to Push for Insulin Cost Caps, but Unlikely to Secure Congressional Approval - Vimarsana News

Biden to Push for Insulin Cost Caps, but Unlikely to Secure Congressional Approval

US President Joe Biden will call for a nationwide cap of $35 a month on out-of-pocket insulin costs during his State of the Union Address on Tuesday, but is unlikely to get his wish as it lacks enough Congressional support.